STEMGENICS

Executive Summary

Stemgenics, Inc. is a private biotechnology company based in San Antonio, Texas, focused on regenerative medicine and cell therapy. Founded in 2008, the company provides stem cell banking services and develops therapeutic applications using patients' own stem cells to treat degenerative conditions. With over a decade of operations, Stemgenics has established itself in the stem cell space, though information on funding, valuation, and clinical pipeline is limited, suggesting a low-profile, privately funded trajectory. The company's business model combines service revenue from stem cell banking with potential future product sales from therapeutic development, positioning it in a growing but competitive market.

Upcoming Catalysts (preview)

• Q3 2026FDA Pre-IND Meeting or IND Filing for Lead Candidate30% success
• Q4 2026Announcement of Strategic Partnership or Licensing Deal40% success
• Q1 2027Publication of Preclinical Data in Peer-Reviewed Journal50% success